Loading…
CIK 0001595855 • 8 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("opaleye-management-inc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ADAGIO MED HLDGS INC | COM | $19K | 0.0%Prev: 0.0% | 18,444 SH | Decreased-92,127 SH |
| ALKERMES PLC | SHS | $13.7M | 1.8%Prev: 1.9% | 490,000 SH | Increased+40,000 SH |
| ALPHA COGNITION INC | COM NEW | $13.5M | 1.8%Prev: 0.1% | 2,070,784 SH | Increased+1,955,642 SH |
| ALUMIS INC | COM | $5.2M | 0.7%Prev: 0.4% | 535,000 SH | Increased-130,000 SH |
| ANNEXON INC | COM | $13.1M | 1.7%Prev: 1.1% | 2,600,000 SH | Increased |
| APOGEE THERAPEUTICS INC | COM | $29.3M | 3.9%Prev: 2.0% | 388,257 SH | Increased+25,000 SH |
| ASSERTIO HOLDINGS INC | COM NEW | $2.6M | 0.3% | 285,000 SH | New |
| ATEA PHARMACEUTICALS INC | COM | $642K | 0.1% | 179,815 SH | New |
| BRIDGEBIO PHARMA INC | COM | $1.4M | 0.2% | 18,319 SH | New |
| CABALETTA BIO INC | COM | $2.0M | 0.3%Prev: 0.3% | 900,000 SH | Increased+91,118 SH |
| CG ONCOLOGY INC | COM | $17.0M | 2.2%Prev: 2.3% | 410,000 SH | Increased |
| CODEXIS INC | COM | $11.1M | 1.5%Prev: 4.4% | 6,789,738 SH | Decreased-6,005,262 SH |
| CRESCENT BIOPHARMA INC | COM | $14.0M | 1.8% | 1,178,300 SH | New |
| DISC MEDICINE INC | COM | $15.9M | 2.1%Prev: 1.8% | 200,000 SH | Increased+6,227 SH |
| EDGEWISE THERAPEUTICS INC | COM | $12.4M | 1.6%Prev: 1.1% | 500,000 SH | Increased |
| ENANTA PHARMACEUTICALS INC | COM | $1.2M | 0.2% | 75,000 SH | New |
| ETON PHARMACEUTICALS INC | COM | $48.4M | 6.4%Prev: 8.8% | 2,860,000 SH | Decreased |
| FORTRESS BIOTECH INC | COM NEW | $4.0M | 0.5% | 1,090,000 SH | New |
| GENERATION BIO CO | COM NEW | $1.8M | 0.2% | 310,000 SH | New |
| GOSSAMER BIO INC | COM | $8.4M | 1.1%Prev: 1.0% | 2,720,000 SH | Increased-5,000 SH |
| HARROW HEALTH INC | COM | $191.3M | 25.2%Prev: 26.6% | 3,905,000 SH | Increased |
| JADE BIOSCIENCES INC | COM NEW | $6.6M | 0.9% | 427,608 SH | New |
| JOURNEY MEDICAL CORP | COM | $7.5M | 1.0%Prev: 1.0% | 975,000 SH | Increased+3,936 SH |
| KARYOPHARM THERAPEUTICS INC | COM NEW | $6.8M | 0.9% | 930,000 SH | New |
| LIQUIDIA CORPORATION | COM NEW | $85.0M | 11.2%Prev: 8.4% | 2,435,000 SH | Increased-180,000 SH |
| MBX BIOSCIENCES INC | COM | $8.2M | 1.1%Prev: 0.6% | 260,000 SH | Increased+7,000 SH |
| MEIRAGTX HOLDINGS PLC | COM | $3.1M | 0.4% | 390,844 SH | New |
| OCULAR THERAPEUTIX INC | COM | $19.4M | 2.6%Prev: 2.6% | 1,595,000 SH | Increased |
| OPUS GENETICS INC | COM | $2.3M | 0.3%Prev: 0.3% | 1,120,000 SH | Increased+20,000 SH |
| PERSPECTIVE THERAPEUTICS INC | COM | $5.0M | 0.7% | 1,184,500 SH | New |
| PROTAGONIST THERAPEUTICS INC | COM | $9.2M | 1.2%Prev: 1.0% | 105,000 SH | Increased |
| PROTALIX BIOTHERAPEUTICS INC | COM | $4.5M | 0.6%Prev: 0.8% | 2,478,176 SH | Decreased-102,380 SH |
| Q32 BIO INC | COM | $708K | 0.1% | 213,363 SH | New |
| RAPT THERAPEUTICS INC | COM NEW | $213K | 0.0% | 150,000 SH | New |
| RELMADA THERAPEUTICS INC | COM | $4.5M | 0.6% | 935,000 SH | New |
| REVOLUTION MEDICINES INC | COM | $8.0M | 1.1%Prev: 0.7% | 100,000 SH | Increased |
| REZOLUTE INC | COM NEW | $14.8M | 2.0%Prev: 1.2% | 6,287,156 SH | Increased+5,383,714 SH |
| RHYTHM PHARMACEUTICALS INC | COM | $35.3M | 4.7%Prev: 6.6% | 330,000 SH | Decreased-131,700 SH |
| RIGEL PHARMACEUTICALS INC | COM | $3.0M | 0.4% | 70,000 SH | New |
| ROCKET PHARMACEUTICALS INC | COM | $3.4M | 0.4% | 955,000 SH | New |
| SANUWAVE HEALTH INC | COM | $29.3M | 3.9%Prev: 5.2% | 981,267 SH | Decreased+1,267 SH |
| SILENCE THERAPEUTICS PLC | ADS | $480K | 0.1% | 78,926 SH | New |
| SOL GEL TECHNOLOGIES | SHS NEW | $19.1M | 2.5%Prev: 0.8% | 453,739 SH | Increased+248,904 SH |
| STOKE THERAPEUTICS INC | COM | $22.1M | 2.9%Prev: 2.3% | 695,000 SH | Increased+12,983 SH |
| SUTRO BIOPHARMA INC | COM SHS | $2.2M | 0.3% | 190,671 SH | New |
| TECTONIC THERAPEUTICS INC | COM | $4.5M | 0.6% | 214,747 SH | New |
| TG THERAPEUTICS INC | COM | $15.9M | 2.1%Prev: 2.7% | 535,000 SH | Decreased |
| TREVI THERAPEUTICS INC | COM | $4.3M | 0.6%Prev: 0.5% | 345,100 SH | Increased-44,900 SH |
| UROGEN PHARMA LTD | COM | $6.3M | 0.8% | 268,423 SH | New |
| VENTYX BIOSCIENCES INC | COM | $2.3M | 0.3% | 251,932 SH | New |
| VOYAGER THERAPEUTICS INC | COM | $4.7M | 0.6% | 1,196,904 SH | New |
| XOMA CORP DEL | COM NEW | $7.8M | 1.0%Prev: 1.4% | 292,590 SH | Decreased+37,503 SH |
| ZENTALIS PHARMACEUTICALS INC | COM | $1.9M | 0.2%Prev: 0.1% | 1,400,906 SH | Increased+1,084,356 SH |
| ZYMEWORKS INC | COM | $2.9M | 0.4%Prev: 0.2% | 108,929 SH | Increased+8,929 SH |
| 13F-HR |
| 0001420506-26-001803 |
| $1.10B |
| View |
| Aug 15, 2025 | Q2 2025 | 13F-HR/A | 0001641172-25-024301 | $494.1M | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001420506-26-001151 | $759.2M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0001641172-25-010914 | $449.2M | View |